Rocket Lab is the second largest US satellite launch provider, poised for significant growth with its upcoming Neutron rocket, expected to start commercial operations next year. The success and timely launch of Neutron are critical, as delays could increase dilution risk due to the equity component of Rocket Lab's recent acquisition of Iridium and refinancing needs. The Iridium acquisition transforms Rocket Lab into a fully integrated space company with global coverage and immediate profitability benefits. Despite current stock weakness presenting a buying opportunity, the key risk remains the execution of the Neutron rocket, which will impact both valuation and dilution.
Rocket Lab shares climbed 7% following Cantor Fitzgerald's reaffirmation of an Overweight rating and a $122 price target, citing the company's strong launch record and diverse customer base. The stock's rise comes amid gains in other space sector sto...
NASA has assigned SpaceX to launch the StarBurst satellite on a Falcon 9 rideshare mission by 2028, intensifying competition for small-launch providers like Rocket Lab. SpaceX shows strong cash flow and a robust backlog, making it a safer choice for ...
Space stocks including Rocket Lab, AST SpaceMobile, and Planet Labs dropped significantly on Friday, with Rocket Lab down 5%. The selloff appears driven by sector rotation rather than company-specific news, as AST SpaceMobile, unrelated to Rocket Lab...
Rocket Lab is transforming from a small-launch specialist into a comprehensive space company, driven by its pending acquisition of Iridium and new defense contracts. Despite a recent share price drop, the company reported record Q2 revenue of $234 mi...
Rocket Lab's stock jumped 6% after the FCC accepted the license-transfer applications for its planned acquisition of Iridium Communications, initiating a public comment period. This procedural step removes an early risk of the deal stalling but is no...
